SHOCK DOCTOR MANUFACTURING AGREEMENT
Stock | HITIQ Ltd (HIQ.ASX) |
---|---|
Release Time | 12 Jun 2025, 10:09 a.m. |
Price Sensitive | Yes |
HITIQ Announces Exclusive Global Agreement with Shock Doctor
- World-first exclusive agreement with leading mouthguard brand Shock Doctor
- Combines HITIQ's PROTEQT concussion management technology with Shock Doctor's design expertise
- Enables rapid global commercialization of PROTEQT, with plans to manufacture 20,000 units in 2025 and 100,000 units in 2026
HITIQ Limited (ASX: HIQ), a pioneer in concussion management, proudly announces an exclusive global agreement with Shock Doctor, the world's leading mouthguard innovator. This landmark agreement marks Shock Doctor's two-year effort to design a mouthguard that will integrate HITIQ's PROTEQT technology. The result is a fully developed, market-ready solution that merges HITIQ's smart sensor technology with Shock Doctor's unmatched global production partner capabilities. Shock Doctor is the only company with the expertise, infrastructure and scale to provide a self-fit mouthguard that can integrate HITIQ technology, enabling reliable worldwide distribution. The co-branded PROTEQT mouthguard, featuring HITIQ's PROTEQT logo and Shock Doctor's 'SHOCK' branding, integrates advanced impact sensors into a high-performance design, setting a new global standard for athlete safety. PROTEQT's concussion management system detects head impacts, assesses risks, and guides recovery with precision, backed by a 7-day telehealth service using the Sports Concussion Assessment Tool (SCAT). Built on HITIQ's proven Nexus iMG technology, validated by elite partners like the AFL and NRL, PROTEQT is ready to protect community athletes worldwide. Strategic partnerships with VAFA (HITIQ's Official Concussion Technology Partner), AFL Barwon, and Westfield Sports High ensure rapid adoption, with more collaborations in development. Shock Doctor's design and production partner prowess enable PROTEQT's rapid production at affordable price points, with production trials confirming a robust supply chain. This exclusive global agreement, built on World Rugby's approval and a U.S. patent for HITIQ's Nexus technology, positions PROTEQT as a global leader in athlete safety.
HITIQ plans to manufacture 20,000 units of the co-branded PROTEQT mouthguard in 2025 and 100,000 units in 2026.
This world-first global agreement with Shock Doctor, the global mouthguard leader, is a defining moment for HITIQ. PROTEQT, now market-ready, combines HITIQ's cutting-edge technology with Shock Doctor's mouthguard excellence to transform concussion management worldwide.